Closing the gap: An urgent need for newborn screening of organic acid disorders in developing countries

Soma Vankwani1, Muhammad Wasim2, Munazza Raza Mirza1

  • 1Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Karachi, Pakistan.

Insights

Implementing newborn screening for organic acid disorders is vital in South Asia. Early detection prevents severe health issues and premature death, improving lives and promoting health equity.

Area of Science:

  • Biochemistry
  • Genetics
  • Public Health

Background:

  • Organic acid disorders are rare inherited metabolic conditions impacting crucial metabolic pathways.
  • Delayed diagnosis leads to severe complications including cardiac issues, respiratory problems, neurodevelopmental disorders, intellectual disability, and premature death.
  • High consanguinity rates in South Asia contribute to a significant burden of these disorders in the region.

Purpose of the Study:

  • To highlight the urgent need for implementing effective newborn screening programs for organic acid disorders in developing countries.
  • To address the gap in screening facilities and treatment availability in resource-limited settings.
  • To emphasize the role of screening in reducing morbidity and mortality associated with these conditions.

Main Methods:

  • This is a narrative review.
  • The review synthesizes current knowledge on organic acid disorders, their impact, and the necessity of newborn screening.
  • It examines the challenges and opportunities for implementing screening programs in developing countries, particularly in South Asia.

Main Results:

  • Organic acid disorders require identification through urinary metabolite investigation and genetic testing via newborn screening.
  • Lack of screening facilities in developing countries results in untreated cases and significant health burdens.
  • Effective newborn screening programs are crucial for early intervention and management.

Conclusions:

  • Implementing effective newborn screening programs for organic acid disorders is essential for reducing morbidity and mortality.
  • Such programs are critical for improving the quality of life for affected children and their families.
  • Establishing these programs promotes global health equity by addressing disparities in healthcare access.